CO Neph & Hypertens (@co_neph_hype) 's Twitter Profile
CO Neph & Hypertens

@co_neph_hype

Insightful editorials and on-the-mark invited reviews covering key subjects in #nephrology & #hypertension. #impactfactor = 2.3

ID: 368267166

linkhttp://www.co-nephrolhypertens.com calendar_today05-09-2011 10:53:53

1,1K Tweet

756 Followers

67 Following

CO Neph & Hypertens (@co_neph_hype) 's Twitter Profile Photo

Current Issue: Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease dlvr.it/RXyryZ

CO Neph & Hypertens (@co_neph_hype) 's Twitter Profile Photo

Current Issue: Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease dlvr.it/RZ6mmK

CO Neph & Hypertens (@co_neph_hype) 's Twitter Profile Photo

Could calprotectin be the game-changer in vascular calcification? Julie Klein and Ana Amaya-Garrido explore its emerging role as both a biomarker and therapeutic target - especially in CKD and aging vessels. ๐Ÿ”— journals.lww.com/co-nephrolhypeโ€ฆ

CO Neph & Hypertens (@co_neph_hype) 's Twitter Profile Photo

New Editor's pick alert! ๐Ÿ“ฃ Read this review on the role of calprotectin in vascular calcification, from our Mineral Metabolism section. Authors highlight its potential as a therapeutic target. Check out this paper here, it's free to read! โฌ‡๏ธ ๐Ÿ”—๐Ÿ‘‰ ow.ly/tBQP50Wy4kq

New Editor's pick alert! ๐Ÿ“ฃ

Read this review on the role of calprotectin in vascular calcification, from our Mineral Metabolism section. Authors highlight its potential as a therapeutic target. 

Check out this paper here, it's free to read! โฌ‡๏ธ  
๐Ÿ”—๐Ÿ‘‰ ow.ly/tBQP50Wy4kq